Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

Ian Hirsch, Daniel A. Goldstein, Ian F. Tannock, Marcus O. Butler, Duncan C. Gilbert*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

40 Scopus citations
Original languageEnglish
Pages (from-to)2236-2237
Number of pages2
JournalNature Medicine
Volume28
Issue number11
DOIs
StatePublished - Nov 2022

Funding

FundersFunder number
National Science FoundationSES-1846832
Medical Research CouncilQQ564477

    Cite this